Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program
Open Access
- 17 January 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Thrombosis Journal
- Vol. 13 (1), 1-8
- https://doi.org/10.1186/s12959-015-0035-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studiesThrombosis Journal, 2013
- Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolismThrombosis Journal, 2013
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary EmbolismThe New England Journal of Medicine, 2012
- Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Guidelines for the Diagnosis, Treatment and Prevention of Pulmonary Thromboembolism and Deep Vein Thrombosis (JCS 2009) - Digest Version -Circulation Journal, 2011
- Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolismPublished by Wiley ,2010
- Venous thromboembolism (VTE) in EuropeThrombosis and Haemostasis, 2007
- A novel long‐acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A Phase II evaluationJournal of Thrombosis and Haemostasis, 2004
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary EmbolismThe New England Journal of Medicine, 1997
- Comparison of perfusion lung scanning and angiography in the estimation of vascular obstruction in acute pulmonary embolismEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990